
    
      The purpose of the present study is to evaluate the simplified treat and extend regimen using
      ranibizumab in eyes with wet age related macular degeneration about best-corrected visual
      acuity, central retinal thickness, the disappearance rate of the morphological change and
      treatment continuous rate.
    
  